Christopher J. Langmead

5.5k citations

85 papers · 4.0k indexed · 1 hit paper · h-index 33

Physiology top 0.5%
- Adenosine and Purinergic Signaling 7
Cellular and Molecular Neuroscience top 0.5%
- Neuroscience and Neuropharmacology Research 26
- Neuropeptides and Animal Physiology 25
- Neurotransmitter Receptor Influence on Behavior 15
Molecular Biology top 2%
- Receptor Mechanisms and Signaling 67
- Nicotinic Acetylcholine Receptors Study 10
- Pharmacological Receptor Mechanisms and Effects 5
Endocrine and Autonomic Systems top 2%
Biological Psychiatry top 5%
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 6

Co-authors: Arthur Christopoulos Jeannette M. Watson Guillaume Lebon K.A. Bennett Charlie Reavill Christopher G. Tate Andrew G. W. Leslie Patricia C. Edwards
Cited by: Physiology Cellular and Molecular Neuroscience Molecular Biology
Journals: Nature (1 paper)Proceedings of the National Academy of Sciences (2 papers)PLoS ONE (2 papers)
Partner nations: Australia United Kingdom United States

In The Last Decade

Christopher J. Langmead

85 papers receiving 3.8k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Christopher J. Langmead

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Langmead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Langmead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Langmead more than expected).

Fields of papers citing papers by Christopher J. Langmead

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Langmead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Langmead. The network helps show where Christopher J. Langmead may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Christopher J. Langmead, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher J. Langmead Line = papers co-authored together Christopher J. Langmead links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Targeting muscarinic receptors for the treatment of alcohol use disorders: Opportunities and hurdles for clinical development British Journal of Pharmacology ·Leigh C. Walker,Kade L. Huckstep,Howard C. Becker,Christopher J. Langmead,Andrew J. Lawrence	2023	7
2	Multipathway In Vitro Pharmacological Characterization of Specialized Proresolving G Protein-Coupled Receptors Molecular Pharmacology ·Jon Merlin,Julia Park,Teresa H. Vandekolk,Stewart A. Fabb,Jeanne Allinne,Roger J. Summers,Christopher J. Langmead,Darren Riddy	2022	16
3	Beyond antipsychotics: a twenty-first century update for preclinical development of schizophrenia therapeutics Translational Psychiatry ·Daisy L. Spark,Alex Fornito,Christopher J. Langmead,Gregory D. Stewart	2022	31
4	M₁ muscarinic receptor activation decreases alcohol consumption via a reduction in consummatory behavior Pharmacology Research & Perspectives ·Leigh C. Walker,Erin J. Campbell,Kate L. Huckstep,Nicola A. Chen,Christopher J. Langmead,Andrew J. Lawrence	2021	9
5	Muscarinic M₄ and M₅ receptors in the ventral subiculum differentially modulate alcohol seeking versus consumption in male alcohol‐preferring rats British Journal of Pharmacology ·Leigh C. Walker,Kate L. Huckstep,Nicola A. Chen,Lexi J. Hand,Craig W. Lindsley,Christopher J. Langmead,Andrew J. Lawrence	2021	17
6	Acetylcholine Muscarinic M4 Receptors as a Therapeutic Target for Alcohol Use Disorder: Converging Evidence From Humans and Rodents Biological Psychiatry ·Leigh C. Walker,Alice E. Berizzi,Nicola A. Chen,Patricia Rueda,Victoria M. Perreau,Katherine Huckstep,Jirawoot Srisontiyakul,Piyarat Govitrapong,Xiaojian Jia,Craig W. Lindsley,Carrie K. Jones,Darren Riddy,Arthur Christopoulos,Christopher J. Langmead,Andrew J. Lawrence	2020	30
7	Structure-based development of a subtype-selective orexin 1 receptor antagonist Proceedings of the National Academy of Sciences ·Jan Hellmann,Matthäus Drabek,Jie Yin,Jakub Gunera,Theresa Pröll,Frank Kraus,Christopher J. Langmead,Harald Hübner,Dorothée Weikert,Peter Kolb,Daniel M. Rosenbaum,Peter Gmeiner	2020	41
8	Crystal structure of the M ₅ muscarinic acetylcholine receptor Proceedings of the National Academy of Sciences ·Ziva Vuckovic,Patrick R. Gentry,Alice E. Berizzi,Kunio Hirata,Swapna Varghese,Geoff Thompson,Emma T. van der Westhuizen,Wessel A. C. Burger,Raphaël Rahmani,Céline Valant,Christopher J. Langmead,Craig W. Lindsley,Jonathan B. Baell,Andrew B. Tobin,Patrick M. Sexton,Arthur Christopoulos,David M. Thal	2019	53
9	Muscarinic M5 receptors modulate ethanol seeking in rats Neuropsychopharmacology ·Alice E. Berizzi,Christina J. Perry,David M. Shackleford,Craig W. Lindsley,Carrie K. Jones,Nicola A. Chen,Patrick M. Sexton,Arthur Christopoulos,Christopher J. Langmead,Andrew J. Lawrence	2018	31
10	G Protein–Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus Pharmacological Reviews ·Darren Riddy,Philippe Delerive,Roger J. Summers,Patrick M. Sexton,Christopher J. Langmead	2017	88
11	Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators Molecular Pharmacology ·Alice E. Berizzi,Patrick R. Gentry,Patricia Rueda,Sandra den Hoedt,Patrick M. Sexton,Christopher J. Langmead,Arthur Christopoulos	2016	23
12	Label-Free Kinetics: Exploiting Functional Hemi-Equilibrium to Derive Rate Constants for Muscarinic Receptor Antagonists Molecular Pharmacology ·Darren Riddy,Céline Valant,Patricia Rueda,William N. Charman,Patrick M. Sexton,Roger J. Summers,Arthur Christopoulos,Christopher J. Langmead	2015	17
13	The properties of thermostabilised G protein-coupled receptors (StaRs) and their use in drug discovery Neuropharmacology ·N.J. Robertson,Ali Jazayeri,James C. Errey,Asma Baig,Edward Hurrell,Andrei Zhukov,Christopher J. Langmead,Malcolm Weir,Fiona H. Marshall	2010	126
14	Contrasting Effects of Allosteric and Orthosteric Agonists on M1 Muscarinic Acetylcholine Receptor Internalization and Down-regulation Journal of Pharmacology and Experimental Therapeutics ·Rachel L. Thomas,Christopher J. Langmead,Martyn Wood,R. A. John Challiss	2009	32
15	Screening for Positive Allosteric Modulators: Assessment of Modulator Concentration-Response Curves as a Screening Paradigm SLAS DISCOVERY ·Christopher J. Langmead	2007	5
16	Structure-Function Studies of Allosteric Agonism at M2 Muscarinic Acetylcholine Receptors Molecular Pharmacology ·Lauren T. May,Vimesh A. Avlani,Christopher J. Langmead,Hugh J. Herdon,Martyn Wood,Patrick M. Sexton,Arthur Christopoulos	2007	98
17	Roof and Floor of the Muscarinic Binding Pocket: Variations in the Binding Modes of Orthosteric Ligands Molecular Pharmacology ·J Alex Goodwin,Edward C. Hulme,Christopher J. Langmead,B.G. Tehan	2007	37
18	SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue European Journal of Pharmacology ·Claire M. Scott,Ellen M. Soffin,Matthew Hill,Peter J. Atkinson,Christopher J. Langmead,Paul Wren,Stefania Faedo,Laurie Gordon,Gary Price,Steve M. Bromidge,Christopher N. Johnson,J.J. Hagan,Jeannette M. Watson	2006	13
19	Neurochemical Changes in LPA1 Receptor Deficient Mice – A Putative Model of Schizophrenia Neurochemical Research ·Claire Roberts,Panida H Winter,Claire S Shilliam,Zoë A. Hughes,Christopher J. Langmead,Peter R. Maycox,Lee A. Dawson	2005	56
20	Probing the Molecular Mechanism of Interaction between 4-n-Butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the Muscarinic M1 Receptor: Direct Pharmacological Evidence That AC-42 Is an Allosteric Agonist Molecular Pharmacology ·Christopher J. Langmead,Victoria A. H. Fry,Ian T. Forbes,Clive L. Branch,Arthur Christopoulos,Martyn Wood,Hugh J. Herdon	2005	90

About Christopher J. Langmead

Christopher J. Langmead is a scholar working on Cellular and Molecular Neuroscience, Physiology and Biological Psychiatry, having authored 85 papers that have together received 4.0k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (67 papers), Neuroscience and Neuropharmacology Research (26 papers), Neuropeptides and Animal Physiology (25 papers), Neurotransmitter Receptor Influence on Behavior (15 papers), Nicotinic Acetylcholine Receptors Study (10 papers), Adenosine and Purinergic Signaling (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). The work is most often cited by research in Physiology (500 citations), Cellular and Molecular Neuroscience (1.9k citations) and Molecular Biology (3.0k citations). Christopher J. Langmead has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Arthur Christopoulos, Jeannette M. Watson, Guillaume Lebon, K.A. Bennett, Charlie Reavill, Christopher G. Tate, Andrew G. W. Leslie, Patricia C. Edwards, Tony Warne and Patrick M. Sexton. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact